The therapeutic efficacy of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> BB‐12<sup>®</sup> in infant colic: A randomised, double blind, placebo‐controlled trial

Rita Nocerino(Ceinge Biotecnologie Avanzate (Italy)), Roberto Berni Canani(Federico II University Hospital), Danilo Ercolini(Federico II University Hospital), Giusy Della Gatta(University of Naples Federico II), Antonio Calignano(University of Naples Federico II), Carmen De(University of Naples Federico II), Linda Cosenza(Ceinge Biotecnologie Avanzate (Italy)), Maria Micillo(University of Naples Federico II), Ylenia Maddalena(Ceinge Biotecnologie Avanzate (Italy)), Antonio Marino(University of Naples Federico II), Anna Maria Iannicelli(University of Naples Federico II), Gaetano Cecere(University of Naples Federico II), Serena Coppola(Ceinge Biotecnologie Avanzate (Italy)), Lorella Paparo(Ceinge Biotecnologie Avanzate (Italy)), Cristina Bruno(Ceinge Biotecnologie Avanzate (Italy)), Laura R. Carucci(Virginia Commonwealth University), Francesca De Filippis(Federico II University Hospital), Carmen Di Scala(Ceinge Biotecnologie Avanzate (Italy))
Alimentary Pharmacology & Therapeutics
December 3, 2019
Cited by 90


Related Papers